Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.18
Views: 320

Dr Laura Spring - Harvard Medical School, Boston, USA

Dr Laura Spring speaks to ecancer at SABCS 2018 about the meta analysis into association of complete response following neoadjuvant chemotherapy with longterm survival in breast cancer.

The study covered 52 studies and over 27,000 patients and it was found that the achievement of pathologic complete response is associated with significantly improved event free survival and overall survival.

Dr Spring explains that a specific analysis was performed into the sub group of patients who achieved the pathologic complete response and then went onto receive additional chemotherapy following surgery or did not receive additional chemotherapy following surgery.

It was found that these groups did equally well showing that the achievement of pathologic complete response is prognostic.

 

Related videos

follow us

Tobacco Dependence e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation